California Jury Says J&J (JNJ) Defectively Designed ASR Hip Device
Tweet
Share
E-mailGet Alerts JNJ Hot Sheet
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) defectively designed ASR hip device, California jury says. The company recalled 93,000 ASR hips in August 2010 after failures.
This was the first trial of 10,750 lawsuits filed over the ASR hip device.
UPDATE - J&J will pay $8.3 million in damages.
Shares of J&J are up 0.4 percent.
This was the first trial of 10,750 lawsuits filed over the ASR hip device.
UPDATE - J&J will pay $8.3 million in damages.
Shares of J&J are up 0.4 percent.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler: PFA survey is most positive for Medtronic, Inc. (MDT)
- Cytokinetics sues Bristol-Myers Squibb over aficamten patent dispute
- Quantum Cyber rejects short-seller's offer to halt reports if lawsuit dropped
Create E-mail Alert Related Categories
Insiders' Blog, LitigationSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
